Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PRL-3 expression in metastatic cancers.

Alberto Bardelli1, Saurabh Saha, Jason A Sager

  • 1The Howard Hughes Medical Institute University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|December 5, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural cues differentially modulate colorectal cancer cell behavior depending on patients' genomic background.

iScience·2026
Same author

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

Cancer discovery·2026
Same author

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

EMBO molecular medicine·2026
Same author

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Cancer discovery·2026
Same author

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

Cancer discovery·2026
Same author

Mapping intratumor heterogeneity across layers for advancing immunotherapy.

Cell·2026

Protein tyrosine phosphatase PRL-3 is specifically elevated in colorectal cancer (CRC) metastases, but not in other cancers or non-metastatic CRC. This finding highlights PRL-3

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis

Background:

  • Protein tyrosine phosphatase PRL-3 is implicated in cancer progression.
  • Elevated PRL-3 expression is observed in liver metastases from colorectal cancer (CRC).

Purpose of the Study:

  • To investigate the cellular basis for elevated PRL-3 expression in CRC metastases.
  • To determine the specificity of PRL-3 expression in metastatic lesions from various cancer types.

Main Methods:

  • Modified in situ hybridization for paraffin-embedded sections.
  • Fluorescence in situ hybridization (FISH) for gene copy number analysis.
  • Immunohistochemistry using anti-PRL-3 antibodies for subcellular localization.

Main Results:

Related Experiment Videos

  • PRL-3 mRNA was highly expressed in nearly all CRC metastases (liver, lung, brain, ovary), but not in normal colon, primary CRCs, or metastases from other cancers (pancreas, stomach, esophagus).
  • Gene amplification was not the primary driver of PRL-3 overexpression.
  • PRL-3 localized to the cell membrane in neoplastic cells and was also detected in tumor endothelium.

Conclusions:

  • PRL-3 exhibits a unique expression pattern, specifically upregulated in CRC metastases regardless of organ site.
  • PRL-3 is also expressed in tumor vasculature, suggesting a potential role in angiogenesis.
  • These findings raise questions about PRL-3's role in cell-type-specific metastasis and angiogenesis.